Jacobs Cindy's Form 4 filing
Achieve Life Sciences, Inc. (ACHV) · filed Sep 8, 2025
- Accession no.
- 0000950170-25-113588
- Filed
- Sep 8, 2025
- Trade date
- Sep 4, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $76.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jacobs CindyCIK 0001229762 | Officer (President & CMO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | MOption exerciseAcquired | +110,000 | $0.00 | $0 | 143,214 | Direct | |
| Sep 4, 2025 | Common Stock | SSaleDisposed | −27,629 | $2.77 | −$76,532.33 | 115,585 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | MOption exerciseDisposed | −84,000 | $0.00 | $0 | 0 | Direct | |
| Sep 4, 2025 | Common Stock | MOption exerciseDisposed | −26,000 | $0.00 | $0 | 104,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.